MediPharm Labs Corp. (OTCMKTS:MEDIF) Short Interest Update

MediPharm Labs Corp. (OTCMKTS:MEDIF) was the target of a significant decrease in short interest in March. As of March 15th, there was short interest totalling 205,100 shares, a decrease of 30.1% from the February 28th total of 293,300 shares. Based on an average trading volume of 173,600 shares, the short-interest ratio is presently 1.2 days.

MediPharm Labs Price Performance

OTCMKTS:MEDIF traded up $0.00 during mid-day trading on Tuesday, reaching $0.07. 68,537 shares of the company’s stock were exchanged, compared to its average volume of 112,435. MediPharm Labs has a one year low of $0.04 and a one year high of $0.09. The business’s fifty day simple moving average is $0.05 and its two-hundred day simple moving average is $0.05.

About MediPharm Labs

MediPharm Labs Corp., a pharmaceutical company, engages in the production and sale of purified, pharmaceutical-quality cannabis extracts, concentrates, active pharmaceutical ingredients, and advanced derivative products in Canada, Australia, Germany, and internationally. The company formulates, processes, packages, and distributes cannabis active ingredients and advanced cannabinoid-based products.